Archive -Daily News

Gene Therapy

Gene Therapy: 2018January27Saturday

The Pharma Exec behind the First Approved Gene Therapy Is Hunting for His Next Big Break

Researcher using gene therapy to battle hearing loss

Novartis steps in to grab ex-US rights to pioneering gene therapy Luxturna with $170M deal

Scotland's Synpromics expands gene therapy work with UCL deal

Gene Therapy: Pipeline of Possibilities but Challenges for Pricing

Why Gene Therapy Is No Longer a Pipe Dream

Gene Therapy Trial Doses First DMD Patient

Non-Profit Says $850000 Gene Therapy Is At Least Twice As Expensive As It Should Be

Paragon Bioservices plans to expand gene therapy manufacturing capacity, add 200-plus jobs near BWI

Novartis, Spark in vision-loss gene therapy deal

Cancer Treatment: 2018January27Saturday

Stiles returns to bench while undergoing cancer treatment

Tessa Jowell is right about cancer treatment: Britain must do better

FDA approves new treatment for certain digestive tract cancers

Lung cancer patient helping lead the charge for improved cancer treatment

'Cervical cancer treatment possible if detected early'

Seven updates in thyroid cancer treatment

What next for Kian Musgrove as schoolboy finishes pioneering cancer treatment?

'Cross-dressing' cells may improve cancer treatment

Patriots fan undergoing cancer treatment treated to AFC game trip

Exercise may increase lifespan after breast cancer treatment

T-cell Therapy: 2018January27Saturday

Eureka nets $60M to take T-cell therapy into the clinic

CAR T-Cell Therapy an Emerging Explosion in Myeloma Paradigm

Two CARTs, Two Charts: Dissecting Returns From T-Cell Therapy M&A

Considerations for CAR T-Cell Therapy in NHL

The Promise of CAR T-Cell Therapy for ALL

SF's Parker Institute makes first investment in T-cell therapy startup

Dr. Brentjens Discusses Potential for CAR T-Cell Therapy in Solid Tumors

John Theurer Cancer Center First NJ Site Certified to offer CAR-T Cell Cancer Therapy

The hottest thing in cancer drug development just won a $9 billion endorsement

Gene-modified, virus-specific T cell therapy shows promise in treating lymphoma, with little toxicity

Stem Cell : 2018January27Saturday

Will State Voters Continue To Pour Money Into Stem Cell Research?

Another stem cell fraud in Japan

Stem Cells Made by Modifying the Epigenome with CRISPR

From Stem Cells to a Functional Heart: The Role of the Mesp1 Gene

Kyoto University Finds Stem Cell Researcher Guilty of Data Fabrication

Scientists culture human placenta stem cells for first time

Discovery may advance neural stem cell treatments for brain disorders

Scientists discover stem cells that build a fly's nervous system

Stem cell bank LifeCell to set up facility in Haryana to produce Mesenchymal Stem Cells

How 'stem cell' clinics became a Wild West for dodgy treatments

Biomedical: 2018January27Saturday

New tool visualizes employment trends in biomedical science

Business Briefs: TARIS Biomedical Announces $25M Series B Financing

UK's leading surgeons mark official launch of £21m NIHR Biomedical Research Centre

In a scientific first, cloned monkeys are born. Will they accelerate biomedical research?

Biomedical research opportunities for WCM-Q alumni highlighted

Curam signs memorandum of understanding with South Korean Biomedical Manufacturing Technology Centre

'Practical Experience': Retired surgeon instructs BCHS biomedical students

Design for Manufacturability Tips for Miniature Biomedical Sensor Circuits

NUI Galway research centre partners with Korean biomedical centre

Premier Biomedical, Inc. CEO Letter -- January, 2018

Biotechnology : 2018January27Saturday

China's blockbuster biotechnology week

What Happened To Puma Biotechnology?

Puma Biotechnology: EU Delivers A Blow - And An Opportunity

Biotechnology startup receives FDA clearance for synthetic bone graft substitute

Biotechnology and Biosafety Policy Under the Trump Administration: The Devil Will Be in the Details

PU to promote industrial biotechnology, bio-refining

The Biotechnology Market is Projected to Grow

Stock Volatility Risk Alert: Puma Biotechnology Inc Realized Volatility Hits An Extraordinary High

BRIEF-Puma Biotechnology Says EMA's CHMP Has Communicated A Negative Trend Vote For Its Breast Cancer ...

Two Biotechnology Stocks Trading Higher Today: Capricor Therapeutics and RedHill Biopharma